These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 21861227

  • 41. Interleukin-8 messenger ribonucleic acid expression correlates with tumor progression, tumor angiogenesis, patient survival, and timing of relapse in non-small-cell lung cancer.
    Yuan A, Yang PC, Yu CJ, Chen WJ, Lin FY, Kuo SH, Luh KT.
    Am J Respir Crit Care Med; 2000 Nov; 162(5):1957-63. PubMed ID: 11069840
    [Abstract] [Full Text] [Related]

  • 42. Expression of choline kinase alpha to predict outcome in patients with early-stage non-small-cell lung cancer: a retrospective study.
    Ramírez de Molina A, Sarmentero-Estrada J, Belda-Iniesta C, Tarón M, Ramírez de Molina V, Cejas P, Skrzypski M, Gallego-Ortega D, de Castro J, Casado E, García-Cabezas MA, Sánchez JJ, Nistal M, Rosell R, González-Barón M, Lacal JC.
    Lancet Oncol; 2007 Oct; 8(10):889-97. PubMed ID: 17851129
    [Abstract] [Full Text] [Related]

  • 43. Smoking status and survival in the national comprehensive cancer network non-small cell lung cancer cohort.
    Ferketich AK, Niland JC, Mamet R, Zornosa C, D'Amico TA, Ettinger DS, Kalemkerian GP, Pisters KM, Reid ME, Otterson GA.
    Cancer; 2013 Feb 15; 119(4):847-53. PubMed ID: 23023590
    [Abstract] [Full Text] [Related]

  • 44. Decreased tumstatin-mRNA is associated with poor outcome in patients with NSCLC.
    Luo YQ, Ming Z, Zhao L, Yao LJ, Dong H, Du JP, Wu SZ, Hu W.
    IUBMB Life; 2012 May 15; 64(5):423-31. PubMed ID: 22473740
    [Abstract] [Full Text] [Related]

  • 45. The prognostic impact of the amount of tobacco smoking in non-small cell lung cancer--differences between adenocarcinoma and squamous cell carcinoma.
    Okamoto T, Suzuki Y, Fujishita T, Kitahara H, Shimamatsu S, Kohno M, Morodomi Y, Kawano D, Maehara Y.
    Lung Cancer; 2014 Aug 15; 85(2):125-30. PubMed ID: 24976334
    [Abstract] [Full Text] [Related]

  • 46. AKT1 polymorphisms and survival of early stage non-small cell lung cancer.
    Kim MJ, Kang HG, Lee SY, Jeon HS, Lee WK, Park JY, Lee EB, Lee JH, Cha SI, Kim DS, Kim CH, Kam S, Jung TH, Park JY.
    J Surg Oncol; 2012 Feb 15; 105(2):167-74. PubMed ID: 21842521
    [Abstract] [Full Text] [Related]

  • 47. Age at diagnosis predicts outcomes in gefitinib-treated female patients with non-small-cell lung cancer.
    Na II, Choe du H, Kim CH, Koh JS, Ryoo BY, Lee JC, Yang SH.
    Lung Cancer; 2010 May 15; 68(2):295-8. PubMed ID: 19576656
    [Abstract] [Full Text] [Related]

  • 48. The clinicopathological and survival differences between never and ever smokers with non-small cell lung cancer.
    Muallaoglu S, Karadeniz C, Mertsoylu H, Ayberk Besen A, Sezer A, Murat Sedef A, Kose F, Ozyilkan O.
    J BUON; 2014 May 15; 19(2):453-8. PubMed ID: 24965406
    [Abstract] [Full Text] [Related]

  • 49. Molecular profiles of non-small cell lung cancers in cigarette smoking and never-smoking patients.
    Szymanowska-Narloch A, Jassem E, Skrzypski M, Muley T, Meister M, Dienemann H, Taron M, Rosell R, Rzepko R, Jarząb M, Marjański T, Pawłowski R, Rzyman W, Jassem J.
    Adv Med Sci; 2013 May 15; 58(2):196-206. PubMed ID: 24451080
    [Abstract] [Full Text] [Related]

  • 50. Significance of Smoking as a Postoperative Prognostic Factor in Patients with Non-small Cell Lung Cancer.
    Hanagiri T, Sugio K, Mizukami M, Ichiki Y, Sugaya M, Yasuda M, Takenoyama M, Yasumoto K.
    J Thorac Oncol; 2008 Oct 15; 3(10):1127-32. PubMed ID: 18827608
    [Abstract] [Full Text] [Related]

  • 51. Methylation of breast cancer susceptibility gene 1 (BRCA1) predicts recurrence in patients with curatively resected stage I non-small cell lung cancer.
    Harada H, Miyamoto K, Yamashita Y, Nakano K, Taniyama K, Miyata Y, Ohdan H, Okada M.
    Cancer; 2013 Feb 15; 119(4):792-8. PubMed ID: 23335114
    [Abstract] [Full Text] [Related]

  • 52. Two microRNA panels to discriminate three subtypes of lung carcinoma in bronchial brushing specimens.
    Huang W, Hu J, Yang DW, Fan XT, Jin Y, Hou YY, Wang JP, Yuan YF, Tan YS, Zhu XZ, Bai CX, Wu Y, Zhu HG, Lu SH.
    Am J Respir Crit Care Med; 2012 Dec 01; 186(11):1160-7. PubMed ID: 23043084
    [Abstract] [Full Text] [Related]

  • 53. The expression of three genes in primary non-small cell lung cancer is associated with metastatic spread to the brain.
    Grinberg-Rashi H, Ofek E, Perelman M, Skarda J, Yaron P, Hajdúch M, Jacob-Hirsch J, Amariglio N, Krupsky M, Simansky DA, Ram Z, Pfeffer R, Galernter I, Steinberg DM, Ben-Dov I, Rechavi G, Izraeli S.
    Clin Cancer Res; 2009 Mar 01; 15(5):1755-61. PubMed ID: 19190132
    [Abstract] [Full Text] [Related]

  • 54. Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer.
    Kim HR, Kim DJ, Kang DR, Lee JG, Lim SM, Lee CY, Rha SY, Bae MK, Lee YJ, Kim SH, Ha SJ, Soo RA, Chung KY, Kim JH, Lee JH, Shim HS, Cho BC.
    J Clin Oncol; 2013 Feb 20; 31(6):731-7. PubMed ID: 23182986
    [Abstract] [Full Text] [Related]

  • 55. New prognostic indicator for non-small-cell lung cancer, quantitation of thymidylate synthase by real-time reverse transcription polymerase chain reaction.
    Shintani Y, Ohta M, Hirabayashi H, Tanaka H, Iuchi K, Nakagawa K, Maeda H, Kido T, Miyoshi S, Matsuda H.
    Int J Cancer; 2003 May 10; 104(6):790-5. PubMed ID: 12640689
    [Abstract] [Full Text] [Related]

  • 56. The prognostic impact of cigarette smoking on patients with non-small cell lung cancer.
    Maeda R, Yoshida J, Ishii G, Hishida T, Nishimura M, Nagai K.
    J Thorac Oncol; 2011 Apr 10; 6(4):735-42. PubMed ID: 21258254
    [Abstract] [Full Text] [Related]

  • 57. Quantitative analysis of carbonic anhydrase IX mRNA in human non-small cell lung cancer.
    Simi L, Venturini G, Malentacchi F, Gelmini S, Andreani M, Janni A, Pastorekova S, Supuran CT, Pazzagli M, Orlando C.
    Lung Cancer; 2006 Apr 10; 52(1):59-66. PubMed ID: 16513206
    [Abstract] [Full Text] [Related]

  • 58. Prognostic signature of protocadherin 10 methylation in curatively resected pathological stage I non-small-cell lung cancer.
    Harada H, Miyamoto K, Yamashita Y, Taniyama K, Mihara K, Nishimura M, Okada M.
    Cancer Med; 2015 Oct 10; 4(10):1536-46. PubMed ID: 26276761
    [Abstract] [Full Text] [Related]

  • 59. Loss of TIMP-3 promotes tumor invasion via elevated IL-6 production and predicts poor survival and relapse in HPV-infected non-small cell lung cancer.
    Wu DW, Tsai LH, Chen PM, Lee MC, Wang L, Chen CY, Cheng YW, Lee H.
    Am J Pathol; 2012 Nov 10; 181(5):1796-806. PubMed ID: 22982189
    [Abstract] [Full Text] [Related]

  • 60. Status of the Parkinson's disease gene family expression in non-small-cell lung cancer.
    Liu QX, Zheng H, Deng XF, Zhou D, Dai JG.
    World J Surg Oncol; 2015 Aug 07; 13():238. PubMed ID: 26245297
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.